NeoGenomics (NEO) Tops Q4 EPS by 2c

NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.5 million versus the consensus estimate of $61.83 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target